InsB9-23 Gene Transfer To Hepatocytes-Based Combined Therapy Abrogates Recurrence Type-1 Diabetes After Islet Transplantation.

Published: 2 February 2022| Version 1 | DOI: 10.17632/gnsk35wyys.1
Contributor:

Description

doi: 10.2337/db19-1249 tabular data related to figure reported (.csv) descriptive document of tabular data (.rtf)

Files

Institutions

Ospedale San Raffaele

Categories

Type 1 Diabetes, Immunotherapy, Islet Transplantation

Licence